Roche honored with a MarketingSherpa award

(PresseBox) (Penzberg, ) The Roche Applied Sciences Imaginality e-mail campaign took top honors at this year's MarketingSherpa Awards in Miami, winning the gold medal for the "Best Limited Series Email Newsletter for Marketing Purposes". The MarketingSherpa Awards ceremony, which is held each year as part of the MarketingSherpa Email Summit in Miami, is the most coveted prize in the e-mail marketing industry. The campaign was implemented by rabbit eMarketing, an international advertising agency specializing in e-mail marketing. The firm has already received numerous important national and international awards for its creative work.

Roche's Imaginality 2008 website created an intelligent link between science and literature. Every month, the site introduced its visitors to another exciting science thriller and points out Roche products that could have played a role in the context of the novel. Each visitor was automatically entered into a drawing for a book or CD. The recently honored e-mail campaign was launched to advertise the Imaginality 2008 site.

MarketingSherpa (www.marketingsherpa.com) is a marketing research institute located in Warren, Rhode Island. As part of its research activities, the institute performs lab tests, conducts surveys of marketing experts and marketing prospects and customers and holds in-depth interviews with marketing officials from notable companies in business-to-business and consumer marketing. MarketingSherpa also analyzes the publications of other marketing research institutes.
Diese Pressemitteilung posten:

About Roche Diagnostics Deutschland GmbH

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.

In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

Weitere Pressemitteilungen dieses Herausgebers

Disclaimer